- Home
- CALC vs CCM Comparison
CALC vs CCM Comparison
Compare CALC & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- CCM
- Stock Information
- Founded
- CALC 2011
- CCM 1997
- Country
- CALC United States
- CCM China
- Employees
- CALC N/A
- CCM N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- CALC Health Care
- CCM Health Care
- Exchange
- CALC Nasdaq
- CCM Nasdaq
- Market Cap
- CALC 20.9M
- CCM 18.2M
- IPO Year
- CALC N/A
- CCM 2009
- Fundamental
- Price
- CALC $1.91
- CCM $8.20
- Analyst Decision
- CALC Strong Buy
- CCM
- Analyst Count
- CALC 3
- CCM 0
- Target Price
- CALC $16.33
- CCM N/A
- AVG Volume (30 Days)
- CALC 33.2K
- CCM 67.4K
- Earning Date
- CALC 05-14-2025
- CCM 05-23-2025
- Dividend Yield
- CALC N/A
- CCM N/A
- EPS Growth
- CALC N/A
- CCM N/A
- EPS
- CALC N/A
- CCM N/A
- Revenue
- CALC N/A
- CCM $52,603,198.00
- Revenue This Year
- CALC N/A
- CCM N/A
- Revenue Next Year
- CALC N/A
- CCM N/A
- P/E Ratio
- CALC N/A
- CCM N/A
- Revenue Growth
- CALC N/A
- CCM N/A
- 52 Week Low
- CALC $1.43
- CCM $3.80
- 52 Week High
- CALC $6.02
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- CALC 56.52
- CCM 67.10
- Support Level
- CALC $1.86
- CCM $6.70
- Resistance Level
- CALC $2.04
- CCM $9.46
- Average True Range (ATR)
- CALC 0.14
- CCM 1.34
- MACD
- CALC 0.05
- CCM 0.16
- Stochastic Oscillator
- CALC 64.79
- CCM 66.60
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.